Prefilled Syringes Market Benefits from Rising Investments in Pharmaceutical Packaging

The global prefilled syringes market size was estimated at USD 8.03 billion in 2024 and is projected to grow at a CAGR of 9.22% from 2025 to 2030. Factors driving the market growth include rising prevalence of chronic diseases, growing adoption of self-injection devices, technological advancements. Additionally, supportive government regulations, increased demand for biologics and biosimilars, and rising shift towards home healthcare are augmenting the market growth. However, stringent government regulations and availability of cheaper alternatives are hindering the market growth.

The rising frequency of chronic diseases and the increasing adoption of self-administered biologics for chronic conditions such as diabetes and auto-immune diseases through the mediums of prefilled syringes, are enhancing growth worldwide in prefilled syringes market. The global elderly population is predicted to increase demand for prefilled syringes. This is due to elderly people are more susceptible to numerous chronic conditions and frequently require healthcare assistance. Approximately 70% of the rheumatoid arthritis patients are female. The symptoms usually begin somewhere between the ages of 30 to 50, though it is possible for them to occur in people of all ages. There are various treatment options for managing symptoms associated with rheumatoid arthritis; for instance, 1mL UniSafe syringes from Owen Mumford have received regulatory approval in Europe, and the medicine is currently available on the market as a combination product with a rheumatoid arthritis drug.

Type Insights

The disposable segment accounted for the largest market share of 95.5% in 2024 and shows the fastest CAGR over the forecast period. Growing self-injecting medication brings need for safety while using syringes, whereas nowadays, with the advent of disposable syringes it is much easier to eliminate the risk to a certain extent, by throwing away the needle immediately after the use of injection so that no cross contamination occurs. Disposable prefilled syringes are required for most diagnostic and therapeutic approaches for chronic diseases since they are essential during medication administration and tests, resulting in rising demand for the product. In June 2021, Hindustan Syringes and Medical Devices Ltd. entered a technical collaboration with Star Syringes of the UK to launch disposable safety needles with sharps injury prevention under the Disposjekt Needle brand.

Material Insights

The glass segment accounted for the largest market share of 71.21% in 2024. Glass acts as a strong barrier against external elements like moisture, oxygen, and light. This is essential for protecting the medication from degradation and ensuring its stability over time. While some plastics offer good barrier properties, they might not be as effective as glass for all medications, especially those sensitive to specific environmental factors. Additionally, glass syringes offer excellent clarity, allowing healthcare providers to easily visualize the medication inside.

Application Insights

The vaccines and immunizations segment accounted for the largest market share of 29.77% in 2024. Numerous vaccines require multiple doses to be administered over a period of time. Prefilled syringes are perfect for this purpose as they eliminate the need for healthcare providers to draw medication from vials, reducing the risk of errors and contamination. Prefilled syringes are easier for patients to use than traditional vials and syringes. This can lead to improved patient compliance, which is essential for the success of vaccination programs. For instance, prefilled syringes can be pre-measured and labeled, making them easier for patients to self-administer at home.

Get a preview of the latest developments in the Prefilled Syringes Market! Download your FREE sample PDF today and explore key data and trends

Distribution Channel Insights

The hospitals segment accounted for the largest market share of 59.9% in 2024. Hospitals are often the preferred choice for patients seeking treatment due to their convenient accessibility and established trust. Patients can also visit hospital for seeking fluid therapy which administer fluids to patients’ body intravenously. Furthermore, the Centers for Disease Control and Prevention (CDC) estimates that 60-88 % sharps-related injuries can be lowered by using safety measures as of such as prefilled syringes.

Regional Insights

North America prefilled syringes market accounted for the 32.0% revenue share in 2024. Preventing needlestick injuries among healthcare professionals is a major priority in developed nations, including the U.S. and Canada. Prefilled syringes with needle guards decrease the possibility of these injuries becoming increasingly prevalent owing to this concern. Prefilled syringes are recommended by the U.S. Centers for Disease Control for vaccine administration owing to their ability to preserve vaccine potency over long storage periods and their ability to save time which is driving the market growth.

Key Prefilled Syringes Companies:

The following are the leading companies in the prefilled syringes market. These companies collectively hold the largest market share and dictate industry trends.